Studies have shown that the NF-κB pathway acts as a vital role in tumor oncogenesis and development, inhibiting the activation of the NF-κB pathway can reduce the migration and metastasis of cholangiocarcinoma cells (28). The gene discussed is NFKB1; the disease is neoplasm.